insights_auto
Why is ORX down 4,15%?
Dive Deeperchevron_right
ORX:STO
Orexo AB
4,50 SEK
arrow_downward
-4,15%(-0,20) 1D
2-ноя., 10:55:14 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
4,92 SEK
High
4,92 SEK
Low
4,50 SEK
Mkt. cap
157,90 млн
Avg. vol.
142,16 миң
Volume
40,84 миң
P/E ratio
0,21
52-wk high
36,00 SEK
52-wk low
4,50 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
Open
4,92 SEK
High
4,92 SEK
Low
4,50 SEK
Mkt. cap
157,90 млн
Avg. vol.
142,16 миң
Volume
40,84 миң
P/E ratio
0,21
52-wk high
36,00 SEK
52-wk low
4,50 SEK
EPS
21,73 SEK
Shares outstanding
35,13 млн
No. of employees
55
News stories
From web sources and news partners
ChartMill
·
40 мүнөт мурун
Stock Market Today: Intel’s Worst Day in Four Decades Drags Chips and the Nasdaq to a Rough October Finish
24/7 Wall St.
·
56 мүнөт мурун
Fidelity’s Broader Nasdaq ETF Has a Surprise for QQQ Investors: Even More Apple
The New York Times
·
8 саат мурун
After Tech Sell-Off, Investors Brace for More Market Volatility
Bloomberg
·
1 саат мурун
US Stocks Halt Selloff as Oil Prices Retreat: Markets Wrap
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB